WTP S123BP is an economical, multi-functional boiler water treatment recommended for the complete control of (base exchanged) softened boiler feed water or RO permeate. WTPS123BP will control residual calcium hardness found in the feed water or from condensate. Contains an alkalinity builder which will adjust hydroxide levels for correct chemical balance, and eliminate dissolved oxygen to prevent pitting corrosion.
WTP S123BP contains catalysed bisulfite to ensure rapid oxygen scavenging and antiscalants/dispersants/sequestering agents: copolymers, polyacrylates, phosphates.
All the raw materials used in the manufacture of WTP S123BP conform to the USA Food and Drug Administration Chapter 1 Subpart D – Specific Usage Additives, §173.310 Boiler Water Additives, under the stated conditions of use.”
|Physical State||Clear liquid|
|Specific Gravity (SG)||1.165|
|Sulphite content||7 % as NaHSO3|
WTP S123BP dosage is proportional to the oxygen content of the feedwater and should be dosed to achieve acceptable pH and sulphite reserves.
Product ml per M3 feed = (74 x ppm Oxygen) + (________375__________)
Boiler concentration factor
This formula will give 30 ppm sulphite as Na2So3
Where Feed temp = 80 0C then ppm Oxygen = 2.9 ppm
TESTING AND CONTROL
WTPTK108 test kit can be used to determine correct levels of Sulphite in the system.
Please refer to material safety data sheet for detailed handling/storage instructions.
WTP S123BP treatments are shipped in 25 litre and 200 litre non-returnable drums.
Field Representatives will work closely with customer personnel to assure the effective application of the water treatment programme. Regular service calls can be provided by qualified personnel.
The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide. The company shall not be held liable for any damage resulting from handling, contact, mis-use or mis-application of the above product. In all instances the user should satisfy themselves that this product is suitable for the anticipated application and should carry out suitable and sufficient risk/COSHH assessments and a method of use statement.